Clinical trial
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
NCT00065273 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00065273 |
|---|---|
| Title | Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay |
| Official title | Severe Aberrant Behavior Among Persons With Mental Retardation. Project III: Behavioral Selectivity of Atypical Neuroleptic Drugs: Effects on Cognitive and Social Behaviors |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mental Retardation, Developmental Delay Disorder |
| Intervention type | Drug |
| Interventions | risperidone, clozapine, olanzapine |
| Enrollment | 50 |
| Start date | Jul 1, 1998 |
| Completion | Jun 1, 2001 |
| First posted | Jul 22, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: